Muyuan operates an integrated model, stretching from feed processing, swine medicine development, and sow breeding, to hog raising and slaughtering. The company is pursuing a growth strategy that focuses on expanding production capacities and improving efficiency in pork production, continuously investing in the expansion of modern, automated farms to reduce production costs and maximize yields.
Cyborg Score Rationale
The company has a market capitalization of ¥339.79 billion with growing analyst coverage, and ten analysts predict share price increases of 15.33% in the coming year. The company was named to the 2024 Forbes Global 2000 list, demonstrating significant scale and stability.
Top Insights
Dual-listed on both Shenzhen and Hong Kong exchanges as of February 2026, marking strategic international expansion
Pig breeding and sales account for approximately 85% of revenues with 90% from China market, while expanding into Vietnam and Philippines
Operates numerous production facilities across Henan, Hubei, and Anhui provinces with recent significant capacity expansion
As of January 2026, the company employs approximately 133,640 employees
Named Competitors
Pig Farming & Processing — Major Chinese competitor in hog breeding and meat processing
Swine Genetics — Chinese competitor in pig farming and animal health
Integrated Pork Production — Large diversified Chinese agribusiness with major pork operations
Recent Developments
(February 2026) Completed Hong Kong Stock Exchange listing, achieving "A+H" dual-listing status
(March 2026) Next earnings report scheduled for March 28, 2026
(2025-2026) Continued capacity expansion and modernization of production facilities
Open the full interactive Muyuan Foods Co., Ltd. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.